PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
LWDHW users had a lower risk of requiring insulin compared with patients using other TCM [PMID:34457016].
LWDHW is associated with significant kidney function preservation and a reduced risk of developing kidney failure [PMID:35387335, PMID:25178949].
LWDHW combined with antihypertensive drugs was more effective in reducing blood pressure and TCM syndrome scores than antihypertensive drugs alone [PMID:23258998].
Administration of LWDHW facilitated locomotor activity, including horizontal and vertical activity [PMID:11527070].
Safety & adverse effects
Drug interactions
Evidence summary
PubMed sources
- 1.PMID: 37101296 (2023) — Immunomodulatory effects of modified Liu-Wei-Di-Huang-Wan Traditional Chinese medicine on allergic asthmatic mice. · Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
- 2.PMID: 12856863 (2003) — The effect of liu-wei-di-huang wan on cytokine gene expression from human peripheral blood lymphocytes. · The American journal of Chinese medicine
- 3.PMID: 35168474 (2022) — Effectiveness of Integrative Chinese-Western Medicine for Chronic Kidney Disease and Diabetes: A Retrospective Cohort Study. · The American journal of Chinese medicine
- 4.PMID: 28231532 (2017) — Paeonifiorin sulfonate as a characteristic marker for specifically inspecting Chinese patent medicine Liu-Wei-Di-Huang-Wan contained sulfur-fumigated Moutan Cortex. · Journal of pharmaceutical and biomedical analysis
- 5.PMID: 34457016